PORTALE DELLA DIDATTICA

Ricerca CERCA
  KEYWORD

28- biomedica

Tesi al Politecnico

Design, prototype development and testing of an antibody-drug conjugate using a novel colchicine derivative

Parole chiave ANTIBODY-DRUG CONJUGATION, BLADDER CANCER

Riferimenti JACEK ADAM TUSZYNSKI

Riferimenti esterni Prof. Afsaneh Lavasanifar, Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Canada

Gruppi di ricerca 28- biomedica

Descrizione This proposal aims to create new single chain and/or single domain nano-particles involving antibody-drug conjugation to optimize both selectivity and specificity for molecular targets in metastatic bladder cancer. The payload for targeted delivery will involve our newly designed anti-mitotic compound CCI-001, which is a colchicine derivative with high potency against bladder cancer cells. In collaboration with Prof. A. Lavasanifar we will design, synthesize and test a novel antibody-drug conjugate for its intended use in clinical applications as an efficacious chemotherapy agent.

Conoscenze richieste drug formulation, simple chemical synthesis, some computational drug design

Note The candidate will spend a period of 3-4 months in Canada in the lab of Prof. Lavasanifar.


Scadenza validita proposta 01/11/2020      PROPONI LA TUA CANDIDATURA




© Politecnico di Torino
Corso Duca degli Abruzzi, 24 - 10129 Torino, ITALY
Contatti